Related references
Note: Only part of the references are listed.Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy
William S. Holland et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines
Claudio Celeghini et al.
INVESTIGATIONAL NEW DRUGS (2011)
Perifosine and CCI 779 Co-Operate to Induce Cell Death and Decrease Proliferation in PTEN-Intact and PTEN-Deficient PDGF-Driven Murine Glioblastoma
Kenneth L. Pitter et al.
PLOS ONE (2011)
Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma Final Results and Analysis of Prognostic Factors
Robert J. Motzer et al.
CANCER (2010)
Another Step Toward the Cure of Metastatic Renal Cell Carcinoma?
Nicholas J. Vogelzang
JOURNAL OF CLINICAL ONCOLOGY (2010)
Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-Bound-Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma
Diana Cirstea et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Perifosine Inhibits Mammalian Target of Rapamycin Signaling through Facilitating Degradation of Major Components in the mTOR Axis and Induces Autophagy
Lei Fu et al.
CANCER RESEARCH (2009)
The Alkylphospholipid Perifosine Induces Apoptosis and p21-Mediated Cell Cycle Arrest in Medulloblastoma
Anil Kumar et al.
MOLECULAR CANCER RESEARCH (2009)
Synergistic Proapoptotic Activity of Recombinant TRAIL Plus the Akt Inhibitor Perifosine in Acute Myelogenous Leukemia Cells
Pier Luigi Tazzari et al.
CANCER RESEARCH (2008)
Perifosine synergistically enhances TRAIL-induced myeloma cell apoptosis via up-regulation of death receptors
Ebenezer David et al.
CLINICAL CANCER RESEARCH (2008)
Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial
Robert J. Motzer et al.
LANCET (2008)
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism
F. Chiarini et al.
LEUKEMIA (2008)
The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway
Heath A. Elrod et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism
X. Wan et al.
ONCOGENE (2007)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours
M Crul et al.
EUROPEAN JOURNAL OF CANCER (2002)
Share Paper
